Company news

Olema Pharmaceuticals, Inc. news in 2026

Olema Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Olema Oncology to Present Combination Data from the Palazestrant and OP-3136 Programs at the 2026 San Antonio Breast Cancer Symposium

November 4, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 3, 2026

Olema Oncology to Participate in Upcoming Investor Conferences

November 2, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 2, 2026

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer

August 13, 2026

Olema Oncology Reports Second Quarter 2026 Financial and Operating Results

August 10, 2026

Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer

May 26, 2026

Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting

May 21, 2026

Olema Oncology Reports First Quarter 2026 Financial and Operating Results

May 12, 2026

Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors

April 29, 2026

Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting

April 21, 2026

Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

April 17, 2026

Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

March 16, 2026

Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

March 15, 2026

Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference

February 19, 2026

Olema Oncology to Participate in Upcoming Investor Conferences

February 4, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 3, 2026

Olema Oncology Announces Departure of Chief Operating and Financial Officer

January 30, 2026

Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference

January 4, 2026

Decks in 2026